NCT06211868View on ClinicalTrials.gov

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2030

Conditions
Cardiovascular DiseasesMetabolic SyndromeNon-Alcoholic Fatty Liver Disease
Interventions
BEHAVIORAL

Digital wearable and AI-human symbiotic lifestyle intervention

Digital wearable and AI-human symbiotic lifestyle intervention

Trial Locations (1)

Unknown

RECRUITING

NUS, Singapore

All Listed Sponsors
collaborator

National University of Singapore

OTHER

lead

National University Hospital, Singapore

OTHER